Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 432

1.

Empfehlungen der Arbeitsgruppe "Photopatchtest" der Deutschen Kontaktallergie-Gruppe (DKG) zur Durchführung des Photopatchtests.

Geier J, Bauer A, Becker D, Brehler R, Breit R, Dickel H, Hofmann S, Kapp A, Lehmann P, Mahler V, Molin S.

J Dtsch Dermatol Ges. 2018 Nov;16(11):1363-1364. doi: 10.1111/ddg.13683_g. No abstract available.

PMID:
30395403
2.

Recommendations for photopatch testing by the Photopatch Test Working Group of the German Contact Dermatitis Research Group (DKG).

Geier J, Bauer A, Becker D, Brehler R, Breit R, Dickel H, Hofmann S, Kapp A, Lehmann P, Mahler V, Molin S.

J Dtsch Dermatol Ges. 2018 Nov;16(11):1363-1364. doi: 10.1111/ddg.13683. No abstract available.

PMID:
30395399
3.

Position statement: topical calcineurin inhibitors in atopic dermatitis.

Remitz A, De Pità O, Mota A, Serra-Baldrich E, Vakirlis E, Kapp A.

J Eur Acad Dermatol Venereol. 2018 Oct 4. doi: 10.1111/jdv.15272. [Epub ahead of print] Review.

PMID:
30288799
4.

Effects of protein quantity and type on diet induced thermogenesis in overweight adults: A randomized controlled trial.

Kassis A, Godin JP, Moille SE, Nielsen-Moennoz C, Groulx K, Oguey-Araymon S, Praplan F, Beaumont M, Sauser J, Monnard I, Kapp AF, Ammon-Zufferey C, Frei N, Guignard L, Delodder F, Mace K.

Clin Nutr. 2018 Aug 10. pii: S0261-5614(18)31346-3. doi: 10.1016/j.clnu.2018.08.004. [Epub ahead of print]

PMID:
30269898
5.

Patient outcomes following implantation with a trifocal toric IOL: twelve-month prospective multicentre study.

Piovella M, Colonval S, Kapp A, Reiter J, Van Cauwenberge F, Alfonso J.

Eye (Lond). 2018 Sep 6. doi: 10.1038/s41433-018-0076-5. [Epub ahead of print]

PMID:
30190549
6.

Eosinophils are a Major Source of Interleukin-31 in Bullous Pemphigoid.

Rüdrich U, Gehring M, Papakonstantinou E, Illerhaus A, Engmann J, Kapp A, Hartmann K, Meyer NH, Gibbs BF, Raap U.

Acta Derm Venereol. 2018 Aug 29;98(8):766-771. doi: 10.2340/00015555-2951.

7.

Phase II Study of the Dual EGFR/HER3 Inhibitor Duligotuzumab (MEHD7945A) versus Cetuximab in Combination with FOLFIRI in Second-Line RAS Wild-Type Metastatic Colorectal Cancer.

Hill AG, Findlay MP, Burge ME, Jackson C, Alfonso PG, Samuel L, Ganju V, Karthaus M, Amatu A, Jeffery M, Bartolomeo MD, Bridgewater J, Coveler AL, Hidalgo M, Kapp AV, Sufan RI, McCall BB, Hanley WD, Penuel EM, Pirzkall A, Tabernero J.

Clin Cancer Res. 2018 May 15;24(10):2276-2284. doi: 10.1158/1078-0432.CCR-17-0646. Epub 2018 Mar 5.

PMID:
29506988
8.

Lokalisierte subepidermale Blasenbildung: nicht immer ein bullöses Pemphigoid, sondern eine diagnostische Herausforderung.

Papakonstantinou E, Schacht V, Kapp A, Raap U.

J Dtsch Dermatol Ges. 2018 Feb;16(2):204-206. doi: 10.1111/ddg.13413_g. No abstract available.

PMID:
29418103
9.

Generalized reactions during skin testing with clindamycin in drug hypersensitivity: a report of 3 cases and review of the literature.

Papakonstantinou E, Müller S, Röhrbein JH, Wieczorek D, Kapp A, Jakob T, Wedi B.

Contact Dermatitis. 2018 Apr;78(4):274-280. doi: 10.1111/cod.12956. Epub 2018 Jan 22. Review.

PMID:
29356000
10.

The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria.

Zuberbier T, Aberer W, Asero R, Abdul Latiff AH, Baker D, Ballmer-Weber B, Bernstein JA, Bindslev-Jensen C, Brzoza Z, Buense Bedrikow R, Canonica GW, Church MK, Craig T, Danilycheva IV, Dressler C, Ensina LF, Giménez-Arnau A, Godse K, Gonçalo M, Grattan C, Hebert J, Hide M, Kaplan A, Kapp A, Katelaris CH, Kocatürk E, Kulthanan K, Larenas-Linnemann D, Leslie TA, Magerl M, Mathelier-Fusade P, Meshkova RY, Metz M, Nast A, Nettis E, Oude-Elberink H, Rosumeck S, Saini SS, Sánchez-Borges M, Schmid-Grendelmeier P, Staubach P, Sussman G, Toubi E, Vena GA, Vestergaard C, Wedi B, Werner RN, Zhao Z, Maurer M; Endorsed by the following societies: AAAAI, AAD, AAIITO, ACAAI, AEDV, APAAACI, ASBAI, ASCIA, BAD, BSACI, CDA, CMICA, CSACI, DDG, DDS, DGAKI, DSA, DST, EAACI, EIAS, EDF, EMBRN, ESCD, GA²LEN, IAACI, IADVL, JDA, NVvA, MSAI, ÖGDV, PSA, RAACI, SBD, SFD, SGAI, SGDV, SIAAIC, SIDeMaST, SPDV, TSD, UNBB, UNEV and WAO.

Allergy. 2018 Jul;73(7):1393-1414. doi: 10.1111/all.13397.

PMID:
29336054
11.

Localized subepidermal blistering: not always bullous pemphigoid but a diagnostic challenge.

Papakonstantinou E, Schacht V, Kapp A, Raap U.

J Dtsch Dermatol Ges. 2018 Feb;16(2):205-207. doi: 10.1111/ddg.13413. Epub 2017 Dec 30. No abstract available.

PMID:
29288600
12.

Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.

Kim SB, Dent R, Im SA, Espié M, Blau S, Tan AR, Isakoff SJ, Oliveira M, Saura C, Wongchenko MJ, Kapp AV, Chan WY, Singel SM, Maslyar DJ, Baselga J; LOTUS investigators.

Lancet Oncol. 2017 Oct;18(10):1360-1372. doi: 10.1016/S1470-2045(17)30450-3. Epub 2017 Aug 8.

13.

Intraepidermal neutrophilic dermatosis type of IgA pemphigus with circulating linear IgA disease antibodies associated with ulcerative colitis.

Papakonstantinou E, Kapp A, Jonkman MF, Raap U.

J Eur Acad Dermatol Venereol. 2018 Jan;32(1):e10-e11. doi: 10.1111/jdv.14436. Epub 2017 Jul 16. No abstract available.

PMID:
28653439
14.

A Phase Ib Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Cobimetinib and Duligotuzumab in Patients with Previously Treated Locally Advanced or Metastatic Cancers with Mutant KRAS.

Lieu CH, Hidalgo M, Berlin JD, Ko AH, Cervantes A, LoRusso P, Gerber DE, Eder JP, Eckhardt SG, Kapp AV, Tsuhako A, McCall B, Pirzkall A, Uyei A, Tabernero J.

Oncologist. 2017 Sep;22(9):1024-e89. doi: 10.1634/theoncologist.2017-0175. Epub 2017 Jun 7.

15.

[Placebo effect in clinical trials with allergen-specific immunotherapy with inhalant allergens].

Wedi B, Wieczorek D, Kapp A.

Hautarzt. 2017 Apr;68(4):297-306. doi: 10.1007/s00105-017-3937-0. German.

PMID:
28194483
16.

[Springer Prize for Dermatology 2017].

Kapp A.

Hautarzt. 2017 Apr;68(4):324-325. doi: 10.1007/s00105-017-3944-1. German. No abstract available.

PMID:
28180911
17.

Insights into Interprotein Electron Transfer of Human Cytochrome c Variants Arranged in Multilayer Architectures by Means of an Artificial Silica Nanoparticle Matrix.

Feifel SC, Stieger KR, Kapp A, Weber D, Allegrozzi M, Piccioli M, Turano P, Lisdat F.

ACS Omega. 2016 Dec 31;1(6):1058-1066. doi: 10.1021/acsomega.6b00213. Epub 2016 Dec 1.

18.

Human basophils are a source of - and are differentially activated by - IL-31.

Raap U, Gehring M, Kleiner S, Rüdrich U, Eiz-Vesper B, Haas H, Kapp A, Gibbs BF.

Clin Exp Allergy. 2017 Apr;47(4):499-508. doi: 10.1111/cea.12875. Epub 2017 Feb 1.

PMID:
28000952
19.

Increased Activity and Apoptosis of Eosinophils in Blister Fluids, Skin and Peripheral Blood of Patients with Bullous Pemphigoid.

Engmann J, Rüdrich U, Behrens G, Papakonstantinou E, Gehring M, Kapp A, Raap U.

Acta Derm Venereol. 2017 Apr 6;97(4):464-471. doi: 10.2340/00015555-2581.

20.

Randomized Phase II Study of Duligotuzumab (MEHD7945A) vs. Cetuximab in Squamous Cell Carcinoma of the Head and Neck (MEHGAN Study).

Fayette J, Wirth L, Oprean C, Udrea A, Jimeno A, Rischin D, Nutting C, Harari PM, Csoszi T, Cernea D, O'Brien P, Hanley WD, Kapp AV, Anderson M, Penuel E, McCall B, Pirzkall A, Vermorken JB.

Front Oncol. 2016 Oct 31;6:232. eCollection 2016.

Supplemental Content

Loading ...
Support Center